Browse the evidence

The T2D prediction model achieves 95.27% ROC-AUC, with 88.48% sensitivity and 87.19% specificity.

The model can be effectively used for early detection of T2D in diverse populations.

The model handles missing data naturally without complex preprocessing and imputation.

The model's ability to manage incomplete data makes it suitable for real-world applications.

Current genomic risk scores alone may not lead to superior weight loss.

Practitioners should not rely solely on genomic risk scores for weight loss strategies.

There is a need for multiomicron integration in personalized nutrition.

Practitioners should consider integrating various omics data for more effective personalized nutrition strategies.

Much remains to be done to make PN interventions more effective and equitable.

Efforts should focus on improving the design and implementation of PN interventions to enhance their effectiveness and accessibility.

The MM diet did not reduce fat mass compared to a usual diet (UD) with a mean difference of -11.36 kg.

Practitioners should be cautious in recommending MM diets for fat loss compared to usual diets.

206,361 individuals (68.6%) had obesity according to the new definition compared to 128,992 individuals (42.9%) according to the traditional definition.

Practitioners should consider the new definition of obesity when assessing patients.

108,650 individuals (36.1%) had clinical obesity according to the new definition, with prevalence increasing with age.

Age should be considered when evaluating obesity risk in patients.

The article proposes measures to strengthen causal inference in dietary trials.

Implementing proposed measures could enhance the reliability of findings in dietary research.

Metabolically healthy individuals experienced lower event rates with increasing body mass index (BMI).

Emphasizing metabolic health may lead to better outcomes even in individuals with higher BMI.

Overweight and obesity are significant health challenges addressed globally by the WHO.

Health practitioners should recognize the global significance of overweight and obesity in their practice.

The discussion on appropriate measures for weight reduction is controversial.

Practitioners should be prepared for diverse opinions on weight loss strategies.

79% of studies testing weight loss as a mechanism found no support or found that interventions were less effective/harmful for fatter people.

Practitioners should be cautious about relying on weight loss as a mechanism for DPP effectiveness.

Participants reported meaningful personal insights from using CGM despite no statistically significant improvements in well-being or health state.

Insights gained from CGM usage can be valuable for athletes, even without measurable health improvements.

Post-ICU patients showed an even distribution of energy and protein intake from oral food consumption throughout the day.

Practitioners should consider the timing of meals to ensure consistent energy and protein intake.

53.5% of participants are at risk of exercise addiction and 46.5% are addicted to exercise.

Practitioners should be aware that a significant portion of regular exercisers may be at risk or addicted to exercise.

The paper developed the first consensual definition of functional training using an international e-Delphi method.

Practitioners can refer to this consensual definition for clarity in functional training.

A proposal was made to avoid the distinction between functional training and the general concept of training.

Practitioners should consider this proposal when defining and applying functional training.

Obesity is fundamentally a chronic metabolic disease characterized by disturbances in energy homeostasis and excessive fat accumulation, driven by a complex interplay of genetic, epigenetic, biological, psychological, and environmental factors.

Understand that obesity is a complex chronic disease, not a moral failing. Effective management requires addressing biological, genetic, and environmental factors, often necessitating medical interventions alongside lifestyle changes.

Energy expenditure can be increased through specific physiological mechanisms independent of physical activity, including UCP1-dependent thermogenesis in brown/beige fat, futile cycling of substrates (creatine, glucose, lipids), and ion pumping (Na+/K+-ATPase, SERCA).

Your body burns calories through several active processes beyond just moving around. These include generating heat in fat tissue (thermogenesis), running 'futile' metabolic cycles that burn energy as heat, and maintaining electrical gradients in cells. While you can't easily control these directly, understanding them helps explain why some medications work better than others. Future treatments may target these specific pathways to help you burn more calories passively.

Tirzepatide and semaglutide are not cost-effective at current net prices, requiring significant discounts to meet cost-effectiveness thresholds.

Healthcare providers should consider the cost-effectiveness of these medications when making treatment decisions.

Preoperative use of GLP-1 receptor agonists is not significantly associated with the odds of postoperative aspiration pneumonia.

Clinicians may reconsider the necessity of withholding GLP-1 RAs preoperatively based on these findings.

Patients using GLP-1 receptor agonists are more likely to be female and diagnosed with both obesity and diabetes compared to nonusers.

Understanding the demographics of GLP-1 RA users can inform targeted interventions and education.

Higher sustained pharmacy costs were the main driver of the cost difference favoring MBS over GLP-1 receptor agonists.

Healthcare providers should consider ongoing medication costs when recommending obesity treatments.